Human medicines

Thymoglobulin

Replacement | Medicines | 06/03/2014

The distributor has informed its supplied customers in a letter dated March 5, 2014, that ten batches were identified during investigations that…

Thymoglobulin Read more

NiQuitin Mini

Recall | Medicines | 27/02/2014

In a letter dated February 21, 2014, the distributor informed the customers it supplied that marginal manufacturing deviations had been identified,…

NiQuitin Mini Read more

Sodium chloride

Recall | Medicines | 27/02/2014

The marketing authorization holder informed its supplied customers in a letter dated February 25, 2014, that increased customer complaints have been…

Sodium chloride Read more

BioMonde BioBag

Recall | Medicines | 25/02/2014

The distributor informed its supplied customers on 03.01.2014 that during the daily control of the sterility tests of the final products of batch…

BioMonde BioBag Read more

Sodium chloride

Replacement | Medicines | 04/02/2014

The marketing authorization holder informed its supplied customers by letter dated February 03, 2014 that infusion bags of 0.9% NaCl 500ml Viaflo with…

Sodium chloride Read more

Imukin

Replacement | Medicines | 03/02/2014

The marketing authorization holder informed its supplied customers in a letter dated 31.01.2014 that a quality deviation with regard to product- and…

Imukin Read more

Saroten Retard

Replacement | Medicines | 23/01/2014

The marketing authorization holder informed its supplied customers in a letter dated 23.01.2014 that the batches listed show deviations in…

Saroten Retard Read more

Octagam 50 mg/ml

Replacement | Medicines | 30/12/2013

The marketing authorization holder informed its supplied customers in a letter dated December 23, 2013, that it cannot be ruled out that a frequent…

Octagam 50 mg/ml Read more

Zithromax i.v.

Recall | Medicines | 19/12/2013

In a letter dated December 19, 2013, the marketing authorization holder informed its customers that an elevated level of a known degradation product…

Zithromax i.v. Read more

Thilorbin eye drops

Replacement | Medicines | 17/12/2013

WABOSAN Arzneimittelvertriebs GmbH has informed its supplied customers by letter dated 12.12.2013 that yellow-orange precipitations have been observed…

Thilorbin eye drops Read more
Email

Further inquiry note